Dabigatran versus warfarin under standard or pharmacogenetic-guided management for the prevention of stroke and systemic thromboembolism in patients with atrial fibrillation: a cost/utility analysis using an analytic decision model

BACKGROUND: Atrial fibrillation (AF) is the most common form of heart arrhythmia and a leading cause of stroke and systemic embolism. Chronic anticoagulation is recommended for preventing those complications. Our study aimed to compare the cost/utility (CU) of three main anticoagulation options: 1)...

Descripción completa

Detalles Bibliográficos
Autores principales: Nshimyumukiza, Léon, Duplantie, Julie, Gagnon, Mathieu, Douville, Xavier, Fournier, Diane, Lindsay, Carmen, Parent, Marc, Milot, Alain, Giguère, Yves, Gagné, Christian, Rousseau, François, Reinharz, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Original Basic Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765702/
https://www.ncbi.nlm.nih.gov/pubmed/23866305
http://dx.doi.org/10.1186/1477-9560-11-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765702/
https://www.ncbi.nlm.nih.gov/pubmed/23866305
http://dx.doi.org/10.1186/1477-9560-11-14

Ejemplares similares